Filing Details

Accession Number:
0000950170-24-012354
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-07 17:50:17
Reporting Period:
2024-02-05
Accepted Time:
2024-02-07 17:50:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Revvity Inc. RVTY Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1440132 S Joel Goldberg 940 Winter Street
Waltham MA 02451-1457
Please See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-05 22,613 $52.65 53,500 No 4 M Direct
Common Stock Disposition 2024-02-05 11,546 $104.08 41,954 No 4 S Direct
Common Stock Disposition 2024-02-05 3,662 $104.80 38,292 No 4 S Direct
Common Stock Disposition 2024-02-05 267 $105.66 38,025 No 4 S Direct
Common Stock Acquisiton 2024-02-05 6,294 $105.62 44,319 No 4 M Direct
Common Stock Disposition 2024-02-05 1,909 $105.62 42,410 No 4 F Direct
Common Stock Disposition 2024-02-05 675 $105.62 41,735 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock NQ Stock Option (right to buy) Disposition 2024-02-05 22,613 $0.00 22,613 $52.65
Common Stock NQ Stock Option (right to buy) Acquisiton 2024-02-05 27,528 $0.00 27,528 $104.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-02-07 No 4 M Direct
27,528 2031-02-05 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 63,709 Indirect By Goldberg Irrevocable 2021 Trust
Footnotes
  1. The transactions reported above in Table I include a cashless exercise of stock options. The cashless exercise for the stock options is reported in four lines. The first line of the cashless exercise transaction is coded M in column 3 of Table I and reports in column 4 the number of shares issuable upon exercise of the options had cash been paid to exercise the options, together with the exercise price with Code A for acquired. The second, third, and fourth lines coded S in column 3 of Table I relate to the same cashless exercise on the first line in Table I and report in Column 4 the number of shares sold from the total number of shares issuable to pay for the cashless exercise of such options with Code D for disposed. The transaction reported in Table II line one above,
  2. (Continued Form Footnote 1) reflects the disposition of the same stock options whose cashless exercise is disclosed in Table I above. The foregoing transactions were effected pursuant to a 10b5-1 trading plan adopted by Mr. Goldberg on August 3, 2023.
  3. The Exercise Price included on the Form 4 filed on February 8, 2017 for the Reporting Person was incorrectly reported due to administrative error.
  4. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $103.57 to $104.56. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  5. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $104.57 to $105.47. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  6. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $105.62 to $105.68. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  7. Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on February 5, 2021.
  8. These shares are being surrendered to satisfy a tax withholding obligation upon vesting of performance-based restricted stock units originally granted on February 5, 2021, as required by the Reporting Person's Performance-based Restricted Stock Unit Agreement.
  9. These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 5, 2021, as required by the Reporting Person's Restricted Stock Agreement.
  10. Securities held in an irrevocable trust for the sole benefit of the reporting person's children. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  11. This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted.
  12. This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.